Remove Headlines Downstream-Processing
article thumbnail

Resolving challenges with product recovery in biopharma manufacturing

Pharmaceutical Technology

At the height of the global pandemic, mAb therapies attracted headlines from their use in the fight against Covid-19, where they were used for the effective treatment of hospitalised patients suffering from the disease. In order to achieve this, increased production efficiency through process intensification is required.